Ultragenyx Pharmaceutical (RARE) Change in Intangibles (2018 - 2026)
Ultragenyx Pharmaceutical (RARE) reported Change in Intangibles of $5.0 million for Q1 2026, down 66.67% year-over-year from $15.0 million in Q1 2025, and down 66.67% on a QoQ basis from $15.0 million in Q1 2025.
Ultragenyx Pharmaceutical (RARE) has 7 years of Change in Intangibles data on file, last reported at $5.0 million in Q1 2026.
- Quarterly Change in Intangibles fell 66.67% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (down 72.22% YoY) and the FY2025 annual result came in at $15.0 million, up 15.38% from the prior year.
- Change in Intangibles declined to $5.0 million in Q1 2026 per RARE's latest filing, from $15.0 million in the prior quarter.
- Across five years, Change in Intangibles topped out at $30.0 million in Q1 2022 and bottomed at $500000.0 in Q4 2023.
- The 5-year median for Change in Intangibles is $3.8 million (2023), against an average of $8.2 million.
- The widest annual swing landed in 2025, when Change in Intangibles jumped 50.0%; it then tumbled 66.67% in 2026.
- Tracing RARE's Change in Intangibles over 5 years: stood at $30.0 million in 2022, then tumbled by 98.33% to $500000.0 in 2023, then changed by 0.0% to $500000.0 in 2024, then soared by 2900.0% to $15.0 million in 2025, then tumbled by 66.67% to $5.0 million in 2026.
- Per Business Quant, the three latest RARE Change in Intangibles figures stand at $5.0 million (Q1 2026), $15.0 million (Q1 2025), and $500000.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2026 | 5.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Mar 31, 2025 | 15.00 Mn |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Jun 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Jun 30, 2023 | 2.50 Mn |
| Jun 30, 2023 | 2.50 Mn |
| Mar 31, 2022 | 30.00 Mn |
| Mar 31, 2022 | 30.00 Mn |
| Dec 31, 2020 | -2.28 Mn |
| Dec 31, 2020 | -2.28 Mn |
| Jun 30, 2018 | 80.60 Mn |
| Jun 30, 2018 | 80.60 Mn |
| Mar 31, 2018 | 130.00 Mn |
| Mar 31, 2018 | 130.00 Mn |